Intermittent fasting means cycling between set times of eating and times of little or no food. In human trials, the main benefit measured is weight loss, and it is real but similar to what people achieve by cutting calories every day. Claims about aging, the brain and immunity come mostly from animal research or short, small studies.
Key Takeaways
- The three most-studied schedules are time-restricted eating (such as 16:8), the 5:2 diet and alternate-day fasting.
- In year-long randomized trials, alternate-day fasting and time-restricted eating with calorie limits produced weight loss similar to daily calorie restriction.
- In a 12-week trial, a 16:8 schedule with no other changes led to about 1 kg of weight loss, which was not significantly different from eating three meals a day.
- A 2026 Cochrane review of 22 trials found little to no difference in weight loss compared with regular dietary advice.
- Most trials last only a few months, so long-term effects in people are not known.
- Tiredness, headache and nausea can occur. People who take glucose-lowering medicine, are pregnant or have a history of disordered eating should get medical advice before fasting.
Evidence grade: Moderate. Many randomized trials and several meta-analyses in adults measured weight and adherence and consistently find intermittent fasting works about as well as daily calorie restriction, but most trials are small and short, and an umbrella review rated most findings low or very low quality.
What Intermittent Fasting Is
The National Institute on Aging (NIA) describes intermittent fasting as an eating pattern that includes hours or days of no or minimal food without missing essential nutrients. It is a schedule, not a list of foods, so it can be combined with almost any eating style. Researchers mostly study the three schedules below.
| Schedule | How it works | Example from a trial |
|---|---|---|
| Time-restricted eating (16:8 and similar) | Eat only within a daily window, often 8 hours, and fast the rest of the day | TREAT trial: eat from noon to 8 p.m., no calories from 8 p.m. to noon |
| Early time-restricted eating | The eating window ends in the afternoon | Liu 2022: eat between 8 a.m. and 4 p.m. |
| 5:2 diet | Two low-calorie days a week, five days of usual eating | Harvie 2011: about 650 kcal on 2 days a week |
| Alternate-day fasting | “Fast days” of about 0–500 kcal alternate with “feast days” | Trepanowski 2017: 25% of energy needs on fast days, 125% on feast days |
This article is our overview. For the weight research in more detail, see intermittent fasting for weight loss, and for considerations specific to women, see intermittent fasting for women.
What Human Trials Measured
Weight compared with daily calorie restriction
The key question is whether fasting beats simply eating less every day. Three well-known randomized trials say it does not:
- Alternate-day fasting. In a one-year trial of 100 adults with obesity, weight loss was nearly identical with alternate-day fasting and daily calorie restriction: 6.8% each at six months and 6.0% vs 5.3% at 12 months, relative to a control group. More people dropped out of the fasting group (38% vs 29%), and they tended to eat more than planned on fast days.
- 5:2-style fasting. In a six-month trial of 107 premenopausal women, two low-calorie days a week led to 6.4 kg of weight loss versus 5.6 kg with continuous calorie restriction, a difference that was not significant.
- Time-restricted eating plus calorie limits. In a 12-month trial of 139 adults with obesity published in the New England Journal of Medicine, everyone followed the same calorie target. Adding an 8 a.m. to 4 p.m. eating window led to 8.0 kg of weight loss versus 6.3 kg without it, and the difference was not statistically significant. Waist size, body fat, blood pressure and other measures followed the same pattern, and adverse events were similar.
Time-restricted eating on its own
The TREAT trial tested 16:8 eating without other diet advice in 116 adults for 12 weeks. The time-restricted group lost 0.94 kg and the three-meals-a-day group lost 0.68 kg; the difference between groups was not significant. In the subgroup that had body scans, the time-restricted group lost more lean mass than the comparison group.
What reviews conclude
A 2021 umbrella review in JAMA Network Open pooled 11 meta-analyses covering 130 randomized trials. The typical trial had 38 participants and lasted 3 months. Intermittent fasting was linked with lower body weight, fat mass, LDL cholesterol, triglycerides, fasting insulin and blood pressure, but also with loss of fat-free mass. Only one finding was supported by high-quality evidence: modified alternate-day fasting for one to two months lowered body mass index compared with a regular diet. About 72% of findings rested on very low-quality evidence.
The 2026 Cochrane review included 22 trials with 1,995 adults with overweight or obesity, each with at least six months of follow-up. Compared with regular dietary advice, intermittent fasting may make little to no difference to weight loss or quality of life, and the evidence on side effects is very uncertain. The authors suggest that people weigh how practical and sustainable a schedule is for them.
Metabolic markers beyond weight
One small, tightly controlled crossover trial in men with prediabetes fed participants enough to keep their weight stable. Eating within a 6-hour window that ended before 3 p.m. for five weeks improved insulin sensitivity, blood pressure and appetite compared with a 12-hour window. In the larger, longer trials above, blood pressure, fasting glucose, insulin and other metabolic measures did not differ meaningfully from daily calorie restriction.
What Is Not Established
- Long-term effects. NIA notes that human trials have mainly been short and have not shown long-term health effects, including on lifespan. Lifespan results are mixed even in animal studies.
- Who it suits. Most research has been done in overweight, middle-aged adults. NIA says studies are still needed to learn whether it is safe for people at a healthy weight and for younger and older people.
- A “best” schedule. The research does not single out 16 hours, or any fasting length, as a threshold for benefits.
- Cell repair, brain and immune claims. Proposed mechanisms such as “metabolic switching” to ketones come largely from animal and laboratory work. They are reasons for research, not proven effects in people. If you are interested in ketosis from diet rather than timing, see our keto diet guide.
Making a Schedule Practical
The NIA-summarized review suggests a gradual, phased-in schedule worked out with a dietitian or nutritionist. One way to phase in is to start with a 12-hour overnight fast and narrow the window over several weeks. During eating windows, the same balanced meals apply: vegetables, fruit, whole grains, protein foods and healthy fats. In the TREAT trial, participants avoided all calories during the fasting window; water, black coffee and plain tea fit that approach.
If you like a flavored drink during long gaps between meals, OPA ION+ Select Electrolyte is a caffeine-free powder made without added sugars that provides magnesium, potassium, sodium from Himalayan pink salt and vitamin B12. It supports everyday hydration; it does not change fasting results or fat loss. If you want a strictly calorie-free fast, check the label first.
Safety and Interactions
Common effects. The Cochrane review lists fatigue, headache and nausea as possible unwanted effects, especially early on. In a small 12-week study of 8-hour time-restricted eating, self-reported side effects, body image, blood counts and disordered-eating scores did not change.
Lean mass and cholesterol. Some trials found more lean-mass loss with fasting, so including enough protein and some strength training is sensible. In the one-year alternate-day fasting trial, LDL cholesterol was higher at 12 months in the fasting group than in the calorie-restriction group.
Talk to a clinician before fasting if you:
- take insulin or other glucose-lowering medicine. In a 12-week trial in adults with type 2 diabetes on these medicines, two low-calorie days a week about doubled the rate of low blood sugar, even with medication reduced;
- take blood-pressure medicine or any medicine that must be taken with food;
- are pregnant, breastfeeding, under 18 or an older adult;
- have a history of disordered eating, or have kidney, liver or other ongoing health conditions.
If you use a potassium-containing electrolyte drink and take ACE inhibitors, angiotensin receptor blockers or potassium-sparing diuretics, ask your doctor or pharmacist first. The NIH Office of Dietary Supplements notes that these medicines can reduce potassium excretion.
Frequently Asked Questions
What are the rules for intermittent fasting?
There is no single rule set. You choose a schedule, such as an 8-hour daily eating window, two low-calorie days a week, or alternating fast and feast days, and keep fasting periods free of calories or very low in calories. Food quality during eating times still matters.
Is 16 hours the best fasting window?
Not necessarily. Trials have used windows from 6 to 8 hours and more. In the 16:8 TREAT trial, weight loss was not significantly different from eating three meals a day, and no fasting length has been shown to be uniquely effective.
Does intermittent fasting work better than cutting calories?
Not in head-to-head trials. Alternate-day fasting, 5:2 and time-restricted eating with calorie limits all produced weight loss similar to daily calorie restriction over 6 to 12 months. Fasting may simply be an easier way for some people to eat less.
Is intermittent fasting safe long term?
It is not known. NIA notes that human trials have been relatively short and mostly in overweight, middle-aged adults. The 2026 Cochrane review included studies of up to 12 months and called for longer follow-up.
Who should not do intermittent fasting?
People who take insulin or other glucose-lowering medicine, are pregnant or breastfeeding, are under 18, or have a history of disordered eating should not start fasting without medical advice. Anyone with an ongoing health condition or regular medication should check with a clinician first.
Sources
- National Institute on Aging. Research on intermittent fasting shows health benefits (summary of de Cabo R, Mattson MP, NEJM 2019). NIH. 2020.
- Varady KA, Cienfuegos S, Ezpeleta M, Gabel K. Clinical application of intermittent fasting for weight loss: progress and future directions. Nature Reviews Endocrinology. 2022.
- Trepanowski JF, Kroeger CM, Barnosky A, et al. Effect of Alternate-Day Fasting on Weight Loss, Weight Maintenance, and Cardioprotection Among Metabolically Healthy Obese Adults: A Randomized Clinical Trial. JAMA Internal Medicine. 2017.
- Harvie MN, Pegington M, Mattson MP, et al. The effects of intermittent or continuous energy restriction on weight loss and metabolic disease risk markers: a randomized trial in young overweight women. International Journal of Obesity. 2011.
- Liu D, Huang Y, Huang C, et al. Calorie Restriction with or without Time-Restricted Eating in Weight Loss. New England Journal of Medicine. 2022.
- Lowe DA, Wu N, Rohdin-Bibby L, et al. Effects of Time-Restricted Eating on Weight Loss and Other Metabolic Parameters in Women and Men With Overweight and Obesity: The TREAT Randomized Clinical Trial. JAMA Internal Medicine. 2020.
- Patikorn C, Roubal K, Veettil SK, et al. Intermittent Fasting and Obesity-Related Health Outcomes: An Umbrella Review of Meta-analyses of Randomized Clinical Trials. JAMA Network Open. 2021.
- Garegnani LI, Oltra G, Ivaldi D, et al. Intermittent fasting for adults with overweight or obesity. Cochrane Database of Systematic Reviews. 2026.
- Sutton EF, Beyl R, Early KS, et al. Early Time-Restricted Feeding Improves Insulin Sensitivity, Blood Pressure, and Oxidative Stress Even without Weight Loss in Men with Prediabetes. Cell Metabolism. 2018.
- Gabel K, Hoddy KK, Varady KA. Safety of 8-h time restricted feeding in adults with obesity. Applied Physiology, Nutrition, and Metabolism. 2019.
- Corley BT, Carroll RW, Hall RM, et al. Intermittent fasting in Type 2 diabetes mellitus and the risk of hypoglycaemia: a randomized controlled trial. Diabetic Medicine. 2018.
- NIH Office of Dietary Supplements. Potassium: Fact Sheet for Health Professionals.
Disclosure: OPA Nutrition sells supplements, including products mentioned in this article. This content is for education only and is not medical advice. Statements about dietary supplements have not been evaluated by the Food and Drug Administration. These products are not intended to diagnose, treat, cure, or prevent any disease. Talk to your healthcare provider before using any supplement, especially if you take medication or have a medical condition.
Written and reviewed by Michael Gonzales, Founder, OPA Nutrition · Last reviewed: · How OPA researches and writes
